Isozymes of glycogen synthase  by Kaslow, Harvey R. & Lesikar, David D.
Volume 172, number 2 FEBS 1598 July 1984 
Isozymes of glycogen synthase 
Harvey R. Kaslow and David D. Lesikar 
Department of Physiology and Biophysics, University of Southern California School of Medicine, 2025 Zonal 
Avenue, Los Angeles, CA 90033, USA 
Received 26 April 1984 
Antisera to rat skeletal muscle glycogen synthase failed to recognize liver glycogen synthase by electroblot 
analysis. The antisera recognized the enzyme in skeletal muscle, heart, fat, kidney, and brain. The results 
support the hypothesis that there are at least two isozymes of glycogen synthase, and that most tissues 
contain a form similar or identical to the skeletal muscle type. There is a virtual absence of the muscle-type 
enzyme in adult rat liver. 
Glycogen synthase Isozyme 
1. INTRODUCTION 
Although glycogen is found in nearly all tissues, 
the glycogen in liver can serve a unique purpose: to 
buffer blood glucose. This buffering function 
depends on the presence of glucose-6-phosphatase, 
which allows the products of glycogenolysis to be 
converted to glucose and released from the cell. In 
other tissues, which lack glucose-6-phosphatase, 
the glucose phosphate produced by glycogenolysis 
is retained for intracellular metabolism. This buf- 
fering function of the liver has also led to the uni- 
que expression of enzymes involved in 
gluconeogenesis, and to the expression of 
glycolytic enzymes different from those found in 
many other tissues. These different enzymes are 
considered to be isozymes. If the buffering func- 
tion of the liver is related to this expression of dif- 
ferent enzymes, it would not be surprising to find 
that the enzymes of glycogen metabolism in liver 
are also different from those found in other 
tissues. 
Evidence is accumulating that these enzymes are 
different. For example, phosphorylase kinase from 
liver is kinetically different from the enzyme found 
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in muscle (for references ee [ 11). Another example 
is glycogen synthase: treating this enzyme from 
rabbit skeletal muscle and liver with CNBr pro- 
duced peptides with different electrophoretic 
mobilities [2,3]. Thus, it has been proposed that 
muscle and liver glycogen synthase are isozymes, 
and that primary structural differences may ac- 
count for kinetic differences that distinguish these 
two forms [2,3]. Here we present immunological 
evidence that supports this proposal, and extends 
it to other tissues in another species: the rat. 
2. EXPERIMENTAL 
Glycogen synthase was assayed in 50 mM 
Tris-HCl (pH 7.8), 15 mg/ml bovine liver 
glycogen, 5 mM EDTA, 2 mM DTT, 30 mM 
NaCl, 0.1 mg/ml heat-treated bovine serum 
albumin, 10 (fig. 1) or 4 (fig.2) mM UDPG, with or 
without 25 mM glucose-6-P at 30°C for 15 min. 
The reaction was terminated by heating at 95°C 
for 1 min, and the [‘4C]glycogen was purified as in 
[4]. The activity in the absence of glucose-6-P was 
divided by the activity in its presence to obtain the 
- / + glucose-6-P activity ratio. A unit of activity 
is defined as 1 pmol/min at 30°C. 
Rat skeletal muscle glycogen synthase was puri- 
fied by modifying procedures in [j-8]. All steps 
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were at 0-4°C and pH 7.6, unless stated otherwise. 
Buffer A is 100 mM NaF, 5 mM EDTA, 2 mM 
DTT, and 1 pg/ml leupeptin. Buffer B is buffer A 
with the addition of 1 mM pABAD and 0.5 mM 
PMSF. One part (approx. 400 g) hindlimb, tho- 
racic, and abdominal muscle from 8 250-g fed 
Sprague-Dawley rats was homogenized (Waring 
blendor) in 4 parts buffer B without DTT and cen- 
trifuged at 23000 x g for 20 min. The filtered 
supernatant was adjusted to pH 5.5 with 1 N acetic 
acid, stirred for 10 min, and centrifuged again at 
23000 x g for 20 min. The glycogen particle was 
resuspended in buffer B plus 50 mM P-glycero- 
phosphate and stored at - 70°C. The purification 
was continued by incubating the glycogen particle 
at 30°C for 1 h after adding 10 units/ml a-amylase 
(Sigma A-0521), 10 mM MgClz, 40 mM 2-mer- 
captoethanol, 5% sucrose, and 0.5 mM PMSF, 
and centrifuging at 78000 x g for 30 min. The 
filtered supernatant was applied to a 30 ml DEAE- 
cellulose (Whatman DE-52) column equilibrated in 
buffer B with 50 mM Tris-HCl, the column 
washed with 300 ml of the same buffer, and the 
enzyme eluted with a 250 ml gradient from 0 to 
350 mM NaCl in buffer A with 50 mM Tris- HCl, 
1 mg/ml bovine glycogen, 5 mM glucose-6-P, and 
0.1 mM UDPG. Fractions containing glycogen 
synthase activity were then applied to a 60 ml Con- 
A-Sepharose column (Pharmacia) equilibrated in 
buffer A omitting leupeptin, with 50 mM Tris- 
HCl, 400 mM NaCl, but without EDTA which can 
cause release of Con-A from the column. The 
column was washed with a 600-ml gradient from 
the equilibration buffer to buffer A without EDTA 
and leupeptin, but with 50 mM fl-glycerophos- 
phate and 10% (v/v) glycerol. The purified enzyme 
(approx. 5OOpg, 5% yield) is eluted in the latter 
buffer with 200 mM glucose, and EDTA is added 
to the eluted enzyme to give 5 mM. At this point 
the enzyme may be contaminated with Con-A. The 
enzyme can be concentrated and separated from 
Con-A by centrifuging at 220000 x g for 2 h. The 
pelleted enzyme was resuspended in 50 mM ,&- 
glycerophosphate, 5 mM EDTA, 2 mM DTT, and 
25% glycerol, and stored at -70°C. Specific 
activities ranged from 15-50 units/mg protein. 
Antisera to the purified enzyme were raised in rab- 
bits and guinea pigs at the Pocono Rabbit Farm by 
injecting 50-1OO~g enzyme at 2-6 week intervals. 
Electroblot analysis was performed essentially as 
in [9]. Tissue samples were electrophoresed in 7.5 
or 10% bisacrylamide gels [lo], gels equilibrated 
first with 0.5 M and then 50 mM NaXP04 (pH 6.5), 
and proteins electroblotted to DBT paper [I l] in 
25 mM Na,P04 (pH 6.5). The paper was blocked 
with ethanolamine, incubated with antisera, wash- 
ed, incubated with ‘2SI-labelled protein A (Amer- 
sham), washed, and used to expose Kodak XAR-5 
film with a Cronex (DuPont) screen at - 70°C [9]. 
For electroblot analysis, tissues were homogen- 
ized in 25 mM Tris-HCl (pH 7.5), 5 mM EDTA, 
1 mM pABAD, 0.5 mM PMSF, 1 .O pg/ml leupep- 
tin either with (kidney, liver, brain) or without 
(muscle, heart, fat) 250 mM sucrose. NaF (100 
mM) was included in the homogenizing buffer, un- 
less the extract was to be incubated to allow endo- 
genous phosphatases to act on glycogen synthase. 
The homogenates were spun at 35000 x g for 20 
min, and the supernatants either used directly 
(fig.1) or incubated and additionally purified. In- 
cubations were for 1 h at 30°C with 14 mM 2-mer- 
captoethanol added. Kidney and brain extracts 
were purified by adsorption to DEAE-cellulose 
(Whatman, DE-52), and elution with an NaCl gra- 
dient in the homogenization buffer with glycerol 
added to 10% (w/w). Liver supernatants were 
purified by pelleting the glycogen particle by cen- 
trifugation at 78000 x g for 2 h. The glycogen par- 
ticle was resuspended in 50 mM &glycerol phos- 
phate (pH 7.6), 5 mM EDTA, 2 mM DTT, 1 mM 
pABAD, and 1 pg/ml leupeptin, with glycerol 
added at 20% (w/w). Extracts were stored at 
- 70°C. Samples were prepared for electrophore- 
sis by heating in 2% SDS, 5% 2-mercaptoethanol, 
and 15% glycerol, in electrophoresis running 
buffer [lo]. 
Protein was determined as in [12]. 
Buffers, protease inhibitors, and assay materials 
were from Sigma, electrophoresis materials from 
Bio-Rad, [‘4C]UDPG from ICN, and [14C]protein 
standards from BRL. 
3. RESULTS 
Antibodies can be used to study protein struc- 
ture, e.g., electroblot analysis is a method of using 
antibodies to determine the electrophoretic mobili- 
ty of proteins without requiring their purification. 
Thus, to study the electrophoretic mobility of un- 
purified rat glycogen synthase we raised antisera 
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against the purified rat skeletal muscle enzyme. 
When we used these antisera to determine the 
mobility of the unpurified rat enzyme, we found 
that antisera from 3 separate animals (2 rabbits 
and 1 guinea pig) failed to detect the enzyme in rat 
liver extracts. 
Fig.1 shows the autoradiogram resulting from 
the analysis of relatively crude extracts. In this ex- 
periment tissues were homogenized and centri- 
fuged, the supernatant assayed for enzyme activity 
and protein, and an aliquot prepared for elec- 
trophoresis (see section 2). Equal amounts of en- 
zyme activity were applied to each lane of the gel. 
The antibody failed to detect any antigenic 
material in the liver sample. Because these samples 
were relatively crude, substantial amounts of pro- 
tein were electrophoresed. To demonstrate that 
saturation of the DPT paper with other proteins in 
12 3 4 5 6 78 
Fig.1. Electroblot analysis of rat tissues with antisera 
(A-1/27/84) against rat skeletal muscle glycogen 
synthase; 35000 x g supernatant fractions were 
electrophoresed (10% gel), electroblotted, and 
immunolabeled (see section 2). Lane 1, 14C-labeled 
proteins: (A) phosphorylase b, M, 92500; (B) bovine 
serum albumin, M, 68000; (C) ovalbumin, Mr 43000; 
and (D) ry-chymotrypsinogen, Mr 25700; (E) p- 
lactoglobulin, M, 18400 and cytochrome c, MI 12300. 
Lanes 2-8, supernatants containing 1 munit glycogen 
synthase activity. Tissues, with activity expressed as 
(munits/mg protein), are: 2, skeletal muscle (27); 3, liver 
(4.5); 4, heart (47); 5, kidney (5.7); 6, fat (8.1); 7, brain 
(6.5); 8, liver (4.5) and heart (47). 
the liver sample did not prevent the binding of 
glycogen synthase to the paper, or sterically hinder 
antibody recognition of bound protein, one lane 
contained a mixture of heart and liver samples. 
The antibody readily detected glycogen synthase in 
this mixture. In contrast to the liver sample, the 
antibody recognized a protein in crude extracts 
with a mobility similar to that for the purified rat 
muscle enzyme (not shown) in every other tissue 
examined: skeletal muscle (from which the im- 
munogen was derived), heart, fat, kidney, and 
brain. 
Although equal amounts of activity were applied 
to each lane of the gel, it is clear that the “‘1 signal 
varies from sample to sample. It is possible that 
antigenically distinct forms of the enzyme pro- 
duced this variation. An alternative explanation is 
that differences in phosphorylation of the enzyme 
lead to differences in antibody recognition. For ex- 
ample, while the purified rabbit skeletal muscle en- 
zyme has been reported to contain up to 6 mol PO4 
per subunit (review [13]), the liver enzyme may 
contain up to 17 mol [ 141. To examine the effect of 
phosphorylation on antibody recognition, we in- 
cubated crude extracts in the absence of NaF at 
30°C for 1 h to allow endogeneous phosphatases 
to reduce the phosphate content of the enzyme. We 
then purified the dephosphorylated enzyme (see 
section 2) to reduce background binding of lz51- 
labelled protein A, and analysed the protein. In 
fig.2 is the autoradiogram of the resulting elec- 
troblot. Although incubating the liver extract in- 
creased the - / + glucose-6-P activity ratio from 
0.12 to 0.45 there was still no substantial increase 
in binding of antibody. When kidney or brain ex- 
tracts were incubated the activity ratio rose from 
0.07 to 1 .Ol (kidney) and from 0.32 to 0.99 (brain). 
There was no alteration in the detection of an- 
tibody binding. It thus appears that this antiserum 
recognizes some sites on these proteins regardless 
of phosphorylation state. 
The original goal of our investigation was to ex- 
amine the electrophoretic mobility of glycogen 
synthase prior to purification. Some controversy 
surrounds the mobility of the native nzyme, par- 
ticularly from liver [7,14]. This controversy may 
arise from the sensitivity of the enzyme to pro- 
teolytic degradation. The relationship between the 
electrophoretic mobility and the molecular mass of 
the native enzyme is further complicated by the 
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Fig.2. Electroblot analysis (7.5% gel) of rat tissues with antisera (A-l/27/84) against rat skeletal muscle glycogen 
synthase. Extracts were either 35000 x g supernatants (muscle, heart nd fat), 78000 x g glycogen particles (liver), or 
DEAE-cellulose purified extracts (brain and kidney) (see section 2). Lane 1, r4C-labeled proteins: (A) phosphorylase 
b, M, 92 500; (B) bovine serum albumin, M, 68000; (C) ovalbumin, M, 43 000; (D) cY-chymotrypsinogen, M, 25 700; (E) 
P-lactoglobulin, Mr 18400 and cytochrome c, MI 12300. Lanes 2-15, extracts containing 0.5 munit glycogen synthase 
activity. Tissues designated with ‘( -NaF)’ were incubated to allow endogenous phosphatases to dephosphorylate 
glycogen synthase (see section 2). Tissues with activity expressed as (munit/mg protein, - / + glucose-6-P activity ratio) 
are: 2, skeletal muscle (26, 0.38); 3, heart (48, 0.26); 4, fat (7.2, 0.16); 5, liver (75.7, 0.12); 6, liver and heart; 7, 
liver( - NaF) (27.7, 0.45); 8, liver( - NaF) and heart; 9, kidney (21.1, 0.07); 10, brain (9.9, 0.32); 11, kidney( - NaF) 
(7.9, 1.01); 12, brain(-NaF) (6.4, 0.99); 13, skeletal muscle. 
observation that phosphorylation can decrease the 
mobility of both purified rabbit skeletal muscle 
[15] and liver [2,3] glycogen synthase. This 
phenomenon may account for the increased elec- 
trophoretic mobility reported for the enzyme pro- 
duced during an in vitro translation of rat liver 
mRNA [16]. This form of the enzyme is probably 
not phosphorylated. 
We have found (not shown) that the purified rat 
skeletal muscle enzyme migrates in SDS gels [lo] in 
multiple bands, usually as a distinct triplet. Elec- 
troblot analysis of the pure enzyme shows a similar 
pattern. Heterogeneity in phosphorylation of the 
enzyme may produce this triplet. It is therefore in- 
teresting to note that incubation, and concomitant 
activation, of the enzyme in crude kidney and 
brain extracts led to marked increases in the 
mobility of the enzyme detected by the antibody 
(fig.2). The increase in mobility may be the result 
of dephosphorylation, proteolysis, or both. 
Studies designed to show that rephosphorylation 
of the enzyme reverses this change in mobility 
should resolve this issue. The ability to conduct 
such studies, without the need for enzyme purifica- 
tion, points out the usefulness of this approach. 
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4. DISCUSSION REFERENCES 
The failure of our antisera to skeletal muscle 
glycogen synthase to recognize liver glycogen syn- 
thase in electroblot analysis strongly supports the 
hypothesis [2,3] that these two enzymes are 
isozymes. In keeping with nomenclature used for 
other isozymes we will refer to the skeletal muscle 
enzyme as ‘M-type’ glycogen synthase, and the 
liver enzyme as ‘L-type’ glycogen synthase. 
Because our antisera recognize the enzyme in 
heart, fat, kidney, and brain under these condi- 
tions, we conclude that these tissues contain an en- 
zyme that resembles the M-type enzyme. Whether 
these enzymes are identical to the skeletal M-type 
enzyme remains to be determined. In addition, 
these tissues may contain L-type glycogen syn- 
thase, or another form of the enzyme, not 
recognized by our antisera. We can conclude, 
however, that in livers from adult rats there is a 
virtual absence of M-type glycogen synthase. 
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